Merck pharmaceutical operations, vaccines, oncology medicines, and global research presence within the s&p 500 healthcare sector, highlighting development, manufacturing, and distribution activities ...
MilliporeSigma, the U.S. and Canadian Life sciences business of Merck KGaA, Darmstadt, Germany, has set out to establish a leading presence in organoid development, starting with its €104 million ...
Zoetis (ZTS) looks undervalued: 17.3x forward P/E, $150 target with 25% upside, plus dividends/buybacks—see key risks and ...
After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on dividend stock investing. My tenure at these premier Wall Street ...
The "Checkpoint Inhibitor Refractory Cancer Drugs Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the Credence Research Inc. offering. The global ...
In 2026, press release marketing continues to evolve as a structured communication strategy that supports local brand visibility, search indexing, and long-term digital authority. Once viewed ...
March 9 - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% tariff on imported branded and patented medicines. Although ...
Good day, and thank you for standing by. Welcome to the Alvotech Q4 2025 and Full Year 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being ...
Ireland’s biopharmaceutical sector continues to thrive amid key financial incentives, proximity to key markets, and favorable regulatory frameworks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results